{
  "title": "Alan Brochstein On Cannabis Investing In 2022",
  "author": "Seeking Alpha",
  "dc:creator": "Seeking Alpha",
  "enclosure": "",
  "guid": "5c235340-7e9e-11ec-95eb-8f330eb273de",
  "pubDate": "Wed, 26 Jan 2022 13:00:00 GMT",
  "link": "https://the-cannabis-investing-podcast.sounder.fm",
  "description": "Cannabis industry expert Alan Brochstein on the current state of cannabis and 2022 catalysts. New York and New Jersey's path to legalization, how to look at consolidation. Direct listings and SPACs, cannabis REITs, Curaleaf and Verano. MedMen/Ascend Wellness deal breakdown unsurprising.",
  "content:encoded": "Cannabis industry expert Alan Brochstein on the current state of cannabis and 2022 catalysts. New York and New Jersey's path to legalization, how to look at consolidation. Direct listings and SPACs, cannabis REITs, Curaleaf and Verano. MedMen/Ascend Wellness deal breakdown unsurprising.",
  "itunes:title": "Alan Brochstein On Cannabis Investing In 2022",
  "itunes:image": "",
  "itunes:author": "Seeking Alpha",
  "itunes:duration": "01:21:06",
  "itunes:explicit": false,
  "itunes:summary": "Cannabis industry expert Alan Brochstein on the current state of cannabis and 2022 catalysts. New York and New Jersey's path to legalization, how to look at consolidation. Direct listings and SPACs, cannabis REITs, Curaleaf and Verano. MedMen/Ascend Wellness deal breakdown unsurprising.",
  "itunes:episodeType": "full",
  "podcast:person": "Seeking Alpha",
  "podcast:transcript": "",
  "podcast:guid": "5c235340-7e9e-11ec-95eb-8f330eb273de"
}